Candesartan Cilexetil
32 mg · Tablet
- Prescription only
- Angiotensin 2 Receptor Blocker
- Active substance
- Candesartan Cilexetil
- Made by
- Alembic Pharmaceuticals Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Candesartan cilexetil). It describes the substance, not this exact product.
Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II).
Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium.
Metabolism and Excretion Because candesartan is not significantly metabolized by the cytochrome P450 system and at therapeutic concentrations has no effects on P450 enzymes, interactions with drugs that inhibit or are metabolized by those enzymes would not be expected.
When candesartan is administered orally, about 26% of the dose is excreted unchanged in urine.
Food with a high fat content does not affect the bioavailability of candesartan after candesartan cilexetil administration.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-01-15
Safety of the active substance
From the US prescribing label for the same active substance (Candesartan cilexetil). It describes the substance, not this exact product.
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue candesartan cilexetil as soon as possible [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.1 )].
- Candesartan cilexetil is contraindicated in patients who are hypersensitive to candesartan.
- Do not co-administer aliskiren with candesartan cilexetil in patients with diabetes [see Drug Interactions (7.4) ].
- Known hypersensitivity to product components (4).
Most common adverse reactions which caused adult patients to discontinue therapy for: Hypertension were headache (0.6%) and dizziness (0.3%) ( 6.1 ).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria4 matching products
Details
| Made by | Alembic Pharmaceuticals Limited |
|---|---|
| Active substance | Candesartan Cilexetil |
| Used in | Heart, blood pressure and circulation |
| Strength | 32 mg |
| Form | Tablet |
| Route | Oral |
| Packs | 100 TABLET in 1 CARTON · 30 TABLET in 1 BOTTLE |
| NDC | 46708-060 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
29 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Tablet29 products
32 mg7
32 mg · 7 companies
- Alembic Pharmaceuticals Inc.
- Alembic Pharmaceuticals Limited · this page
- ANI Pharmaceuticals, Inc.
- Golden State Medical Supply, Inc.
- Mylan Pharmaceuticals Inc.
- Viona Pharmaceuticals Inc
- Zydus Lifesciences Limited
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.